BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang HN, Wang Y, Zhang SY, Bai L. Emerging roles of the acid sphingomyelinase/ceramide pathway in metabolic and cardiovascular diseases: Mechanistic insights and therapeutic implications. World J Cardiol 2025; 17(2): 102308 [PMID: 40061281 DOI: 10.4330/wjc.v17.i2.102308]
URL: https://www.wjgnet.com/1949-8462/full/v17/i2/102308.htm
Number Citing Articles
1
Zijie Xu, Yujia Zhou, Ruijie Xie, Zhongxing Ning. Metabolomics uncovers the diabetes metabolic network: from pathophysiological mechanisms to clinical applicationsFrontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1624878
2
Yujie Huang, Yu Ding, Xiaoyu Guo, Lingfang Huang, Xiangqiong Meng, Wenjun Jiang, Zejun Wang, Tian Yang, Minghai Zheng, Xiaoling Tan. Chronic hypoxia induces liver injury via PKCδ/ASMase-driven ceramide accumulation and endoplasmic reticulum stress in ratsLipids in Health and Disease 2025; 24(1) doi: 10.1186/s12944-025-02761-w
3
Hee Ji Yoon, Wan Hui Han, Sang Bo Kim, Won Gyeong Lee, Seo Young Choi, Byung Jo Choi, Minyeong Pang, Min‐Koo Choi, Jihoon Lee, Im‐Sook Song, Min Hee Park, Hee Kyung Jin, Jae‐sung Bae. KARIs, Ghrelin Receptor Agonists With Excellent Brain Permeability, Increase Food Intake and Attenuate the Muscle Loss in MiceJournal of Cachexia, Sarcopenia and Muscle 2026; 17(2) doi: 10.1002/jcsm.70277
4
Yuehong Chen, Jingyu Yang, Geng Yin, Qibing Xie. The Acid sphingomyelinase/ceramide System in Idiopathic Inflammatory Myopathies: a Potential Treatment TargetInflammation 2026; 49(1) doi: 10.1007/s10753-026-02458-x